126 related articles for article (PubMed ID: 15236291)
1. Bone mineral density in childhood acute lymphoblastic leukemia (ALL) during and after treatment.
van der Sluis IM; de Muinck Keizer-Schrama SM; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2004 Aug; 43(2):182-3; discussion 184. PubMed ID: 15236291
[No Abstract] [Full Text] [Related]
2. Low bone mineral density in childhood acute lymphoblastic leukemia.
Naithani R; Desai A
Indian Pediatr; 2009 Jun; 46(6):542-3; author reply 543-4. PubMed ID: 19556673
[No Abstract] [Full Text] [Related]
3. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density decrements and children diagnosed with cancer.
Pagano-Therrien J; Santacroce SJ
J Pediatr Oncol Nurs; 2005; 22(6):328-38. PubMed ID: 16216895
[TBL] [Abstract][Full Text] [Related]
5. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bone mineral density at different phases of therapy of childhood all.
Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M
Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
8. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
9. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
[No Abstract] [Full Text] [Related]
10. Severe skeletal complications in a child with acute lymphoblastic leukemia.
Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G
Pediatr Hematol Oncol; 2006 Sep; 23(6):523-5; author reply 527-8. PubMed ID: 16849284
[No Abstract] [Full Text] [Related]
11. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
12. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
[TBL] [Abstract][Full Text] [Related]
14. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
[TBL] [Abstract][Full Text] [Related]
15. Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design.
Rai SN; Hudson MM; McCammon E; Carbone L; Tylavsky F; Smith K; Surprise H; Shelso J; Pui CH; Kaste S
Contemp Clin Trials; 2008 Sep; 29(5):711-9. PubMed ID: 18586578
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
Högler W; Shaw N
Cancer; 2009 Oct; 115(20):4885; author reply 4885-6. PubMed ID: 19637349
[No Abstract] [Full Text] [Related]
17. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
18. Bone mass after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Hertz H; Müller J; Michaelsen KF; Mølgaard C
J Clin Oncol; 2001 Jun; 19(11):2970-1. PubMed ID: 11387373
[No Abstract] [Full Text] [Related]
19. My aching bones: skeletal complications of acute lymphoblastic leukemia.
Nachman JB
Pediatr Blood Cancer; 2006 Jan; 46(1):1. PubMed ID: 16261585
[No Abstract] [Full Text] [Related]
20. [Bone metabolism disturbances in anorexia nervosa].
Szymańska U; Jagielska G; Tomaszewicz-Libudzic C; Przedlacki J
Wiad Lek; 2007; 60(1-2):68-72. PubMed ID: 17607972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
